Completed PHASE3 INTERVENTIONAL 2-arm NCT01935817

Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated With Peg-IFN-a and RBV

Sponsor: University of Catania

Interventions Placebo Silybin 94 mg + vitamin E 90 mg + phospholipids 194 mg complex

Updated 5 times since 2017 Last updated: Sep 4, 2013 Started: Jun 30, 2010 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Liver Fibrosis, this trial is completed. The trial is conducted by University of Catania and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Catania

Data source: University of Catania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Catania, Italy